Other emerging therapeutic approaches, such as targeting tumor metabolism processes, KRAS-targeted siRNA, anti-RAS vaccines, offer hope for inhibiting tumor growth and providing a potential treatment option for KRAS-mutant colorectal cancer. The gene discussed is KRAS; the disease is neoplasm.